Is ERα a Tamoxifen Predictive Factor in ERα Negative Breast Cancer in Premenopausal Women?

被引：0
|
作者：
Kallstrom, A-C
Ferno, M.
Jonsson, P. E.
Landberg, G.
Nordenskjold, B.
Stal, O.
机构：
[1] Helsingborgs Lasarett, Helsingborg, Sweden
[2] Linkoping Univ, S-58183 Linkoping, Sweden
[3] Lund Univ, S-22100 Lund, Sweden
[4] Lund Univ, Malmo, Sweden
[5] Lund Univ, Malmo Univ Hosp, Malmo, Sweden
[6] Univ Manchester, Manchester M13 9PL, Lancs, England
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PD05-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD05-06
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
    Li, Yuanyuan
    Meeran, Syed M.
    Tollefsbol, Trygve O.
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
    Yuanyuan Li
    Syed M. Meeran
    Trygve O. Tollefsbol
    Scientific Reports, 7
  • [23] Molecular changes in premenopausal ER plus breast cancer after ovariectomy
    Ben Haynes
    Ginsburg, O.
    Gao, A.
    Folkerd, E.
    Afentakis, M.
    Han Thi Pham
    Le Hong Quang
    Ta Van To
    Nguyen Van Dinh
    Dowsett, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 193 - 193
  • [24] Androgen receptor expression can predict benefit of tamoxifen treatment in patients with ER negative breast cancer
    Hilborn, Erik
    Gacic, Jelena
    Fornander, Tommy
    Skog, Lambert
    Nordenskjold, Bo
    Stal, Olle
    Jansson, Agneta
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [25] Hip circumference is associated with the risk of premenopausal ER−/PR− breast cancer
    G Fagherazzi
    N Chabbert-Buffet
    A Fabre
    G Guillas
    M-C Boutron-Ruault
    S Mesrine
    F Clavel-Chapelon
    International Journal of Obesity, 2012, 36 : 431 - 439
  • [26] Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma
    Gruvberger-Saal, Sofia K.
    Bendahl, Paer-Ola
    Saal, Lao H.
    Laakso, Mervi
    Hegardt, Cecilia
    Eden, Patrik
    Peterson, Carsten
    Malmstroem, Per
    Isola, Jorma
    Borg, Ake
    Fernoe, Marten
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1987 - 1994
  • [27] ERβ2 and ERβ5 inhibit proliferation and promote Tamoxifen-sensitivity of breast cancer cells
    Feldmann, C.
    Liu, H.
    Kratz, A.
    Mieth, M.
    Eucker, J.
    Possinger, K.
    Elstner, E.
    Zang, C.
    ONKOLOGIE, 2010, 33 : 119 - 119
  • [28] ERβ2 and ERβ5 inhibit proliferation and promote Tamoxifen-sensitivity in breast cancer cells
    Feldmann, C.
    Liu, H.
    Kratz, A.
    Mieth, M.
    Eucker, J.
    Possinger, K.
    Elstner, E.
    Zang, C.
    ONKOLOGIE, 2011, 34 : 209 - 209
  • [29] Relation of family history of cancer to risk of ER plus , ER-, and triple-negative breast cancer in African American women
    Bethea, Traci N.
    Rosenberg, Lynn
    Castro-Webb, Nelsy
    Lunetta, Kathryn L.
    Sucheston, Lara E.
    Ruiz-Narvaez, Edward A.
    Charlot, Marjory
    Park, Song Y.
    Bandera, Elisa V.
    Troester, Melissa A.
    Ambrosone, Christine B.
    Palmer, Julie R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [30] Valproic acid restores ERα and antiestrogen sensitivity to ERα-negative breast cancer cells
    Fortunati, N.
    Bertino, S.
    Costantino, L.
    De Bortoli, M.
    Compagnone, A.
    Bandino, A.
    Catalano, M. G.
    Boccuzzi, G.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 314 (01) : 17 - 22
12345